Project Overview 

Disease progression and drug response can be driven by changes in the abundance of specific cell types or states, particularly when treatments are designed to target these populations. Single-cell and spatial transcriptomics combined with differential abundance analysis enable quantification of cell-type and cell-state changes. This provides clear insight into which cellular groups are expanded, depleted, or reprogrammed by disease or treatment.

Services Provided

• Single-cell and spatial transcriptomics analysis.
• Enrichment methods for differential cell-type/state abundance.
• Integration of publicly available datasets to label previously described cell-types.

Deliverables & Benefits

• Interactive reports highlighting disease-associated cell states/types.
• Stratification of patients into clinically meaningful subgroups.
• Target discovery through precise disease-mapping at cellular resolution..

Why Choose Lucid Analytics? 

With a deep understanding of life sciences and cutting-edge AI expertise, Lucid Analytics supports clients in accelerating innovation and driving impactful R&D outcomes.

Ready to Transform Your Data? 

Interested in how we can help with your next project? Contact us today to explore how data can drive your R&D success.